SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection
NCT03217617
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
SCID, X-Linked
Interventions
BIOLOGICAL:
Direct intravenous injection of ivlv-X1 lentiviral vector
Sponsor
Shenzhen Geno-Immune Medical Institute